×
About 342,194 results

ALLMedicine™ Hypertension Center

Research & Reviews  152,589 results

ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension.
https://doi.org/10.1016/j.jacr.2021.02.013
Journal of the American College of Radiology : JACR; , Pinchot JW et. al.

May 7th, 2021 - Cirrhosis is a heterogeneous disease that cannot be studied as a single entity and is classified in two main prognostic stages: compensated and decompensated cirrhosis. Portal hypertension, characterized by a pathological increase of the portal pr...

The association between insulin sensitivity indices, ECG findings and mortality: a 40-y...
https://doi.org/10.1186/s12933-021-01284-9
Cardiovascular Diabetology; Moshkovits Y, Rott D et. al.

May 7th, 2021 - Type 2 Diabetes is a major risk factor for cardiovascular (CV) mortality. Insulin resistance can be evaluated non-invasively by insulin sensitivity indices (ISI) such as the Mcauley index (MCAi), which is a function of the fasting insulin and trig...

Clinical impact of blood pressure variability in patients with COVID-19 and hypertension.
https://doi.org/10.1097/MBP.0000000000000544
Blood Pressure Monitoring; Nam JH, Park JI et. al.

May 7th, 2021 - This study aimed to investigate the relationship between blood pressure variability (BPV) and clinical outcomes in patients with coronavirus disease 2019 (COVID-19) and hypertension. A total of 136 patients hospitalized with COVID-19 were enrolled...

Persistent hypertension after preeclampsia in a group of Cameroonians: Result of a cros...
https://doi.org/10.1111/jch.14260
Journal of Clinical Hypertension (Greenwich, Conn.); Nganou-Gnindjio CN, Kenmogne D et. al.

May 7th, 2021 - Preeclampsia/eclampsia significantly increases the risk of future hypertension. Several factors may be involved in this process. The purpose of this study was to identify them in Cameroonians. We conduct a cross-sectional study including women age...

Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the...
https://doi.org/10.1007/s11906-021-01142-9 10.1002/cphy.c120027 10.1016/j.tem.2018.01.002 10.1038/nrgastro.2017.119 10.1371/journal.pone.0096053 10.18632/oncotarget.18528 10.1016/j.jcmgh.2016.03.007 10.1113/jphysiol.2011.219691 10.1038/nrgastro.2017.38 10.1073/pnas.1400062111 10.1016/j.cld.2013.12.001 10.1152/physiolgenomics.00136.2014 10.1161/HYPERTENSIONAHA.120.13896 10.1161/JAHA.119.014373 10.1080/19490976.2018.1441664 10.1016/j.celrep.2018.09.058 10.3748/wjg.v25.i39.5897 10.1155/2014/797898 10.1007/978-3-319-22671-2_11 10.1126/science.1064921 10.1038/nature03120 10.1038/nature03049 10.1101/gad.1953310 10.1038/nrg2290 10.1016/j.trecan.2019.08.003 10.1016/j.trsl.2019.07.007 10.1111/jcmm.12950 10.3748/wjg.v20.i23.7312 10.1038/s41598-018-36297-0 10.3181/0711-RM-321 10.1258/ebm.2011.010349 10.3109/10641963.2015.1116543 10.3390/ijms17040451 10.1038/s41440-019-0248-0 10.1098/rstb.2011.0336 10.33549/physiolres.932364 10.1038/s41440-020-0405-5 10.1186/s12944-019-1028-1 10.1038/s41371-018-0097-3 10.1080/10641963.2016.1226889 10.1038/hr.2016.147 10.1016/j.jash.2015.07.013 10.1016/j.ijcard.2014.09.204 10.1038/jhh.2013.117 10.26355/eurrev_202011_23828 10.1080/10641963.2019.1571597 10.1186/s12967-018-1604-6 10.1016/j.jash.2014.03.324 10.1097/FJC.0b013e318203759b 10.1074/jbc.M109.098004 10.1016/j.devcel.2008.07.008 10.1093/ajh/hpz112 10.1182/blood-2011-08-373886 10.1016/j.phrs.2012.10.007 10.1097/MNH.0000000000000293 10.1186/s40168-016-0222-x 10.1161/HYP.0000000000000065 10.1057/biosoc.2011.1 10.3390/ijerph110403956 10.1016/j.jpeds.2009.01.015 10.1038/ijo.2009.259 10.1152/ajpregu.00680.2007 10.1681/ASN.2009111111 10.1097/HJH.0000000000000551 10.1038/ki.2008.184 10.1016/j.lfs.2006.08.009 10.1152/ajprenal.00063.2004 10.1016/j.jnutbio.2017.02.003 10.1007/s11906-016-0696-8 10.1016/j.envres.2016.01.010 10.3892/etm.2017.5371 10.3389/fphys.2018.01433 10.1097/00004872-200018060-00006 10.3892/etm.2016.3506 10.1016/j.jada.2010.03.018 10.1002/dmrr.488 10.4103/jrms.JRMS_982_17 10.1016/j.molmet.2013.11.006 10.1111/micc.12104 10.1093/jn/130.5.1247 10.1113/JP274623 10.1155/2016/2489479 10.1161/CIRCULATIONAHA.116.023926 10.1161/CIRCRESAHA.113.301824 10.1097/HCO.0000000000000532 10.1152/ajpheart.00389.2018 10.1038/s41420-019-0153-y 10.3389/fmed.2019.00280 10.1152/ajpendo.00348.2014 10.1038/s41598-020-77539-4 10.1161/HYPERTENSIONAHA.110.154187 10.17219/acem/93728 10.1159/000490093 10.1186/s12929-017-0357-5 10.1016/j.jnutbio.2018.03.010 10.1161/01.HYP.0000202568.01167.B6 10.1093/ajh/hpu157 10.1038/jhh.2014.30 10.1161/01.CIR.0000126823.07732.D5 10.1038/sj.ejcn.1602138 10.1111/jch.13075 10.1080/10641963.2016.1226888 10.1016/j.jacc.2005.04.040 10.1038/s41467-017-02401-7 10.1097/00005344-200310000-00001 10.3892/mmr.2015.4558 10.1016/j.bbrc.2019.11.055 10.1038/srep35302 10.1111/1440-1681.12611 10.1161/CIRCULATIONAHA.109.864629 10.1007/s00418-020-01847-z 10.1007/s12013-009-9063-6 10.1079/NRR200116 10.1016/j.jash.2017.04.006 10.1146/annurev-physiol-021317-121134 10.1161/HYPERTENSIONAHA.116.08966 10.1097/MD.0000000000006417 10.1291/hypres.28.819 10.1097/HJH.0000000000001373 10.1111/jcmm.14863 10.1161/HYPERTENSIONAHA.109.144428 10.1161/HYPERTENSIONAHA.111.00892 10.3892/etm.2016.3667 10.1097/01.crd.0000223656.06812.ae 10.1136/bmj.g3961 10.1373/clinchem.2012.195776 10.3389/fendo.2019.00319 10.1210/jc.2015-2357 10.1186/s40608-018-0199-z 10.1016/j.soard.2013.11.010 10.1186/s12920-016-0180-y 10.1152/ajpgi.00048.2011 10.1146/annurev-food-030117-012830 10.1002/mnfr.201900616 10.1161/HYPERTENSIONAHA.118.11695 10.1161/HYPERTENSIONAHA.114.03469 10.1186/s12944-020-01259-x 10.1038/s41598-020-63475-w 10.1161/HYPERTENSIONAHA.118.12588 10.1007/s11906-017-0722-5 10.1016/j.kint.2016.06.033 10.1152/physiolgenomics.00089.2016 10.1073/pnas.1215927110 10.1111/jcmm.14684 10.1016/j.phrs.2018.06.012 10.1016/j.chom.2018.10.001 10.1371/journal.pmed.1003282
Current Hypertension Reports; Golonka RM, Cooper JK et. al.

May 7th, 2021 - To review the current knowledge on interactions between dietary factors and microRNAs (miRNAs) in essential hypertension (EH) pathogenesis. There exists an integration of maintenance signals generated by genetic, epigenetic, immune, and environmen...

see more →

Guidelines  571 results

ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension.
https://doi.org/10.1016/j.jacr.2021.02.013
Journal of the American College of Radiology : JACR; , Pinchot JW et. al.

May 7th, 2021 - Cirrhosis is a heterogeneous disease that cannot be studied as a single entity and is classified in two main prognostic stages: compensated and decompensated cirrhosis. Portal hypertension, characterized by a pathological increase of the portal pr...

Screening for Hypertension in Adults: US Preventive Services Task Force Reaffirmation R...
https://doi.org/10.1001/jama.2021.4987
JAMA , Krist AH et. al.

Apr 27th, 2021 - Hypertension is a prevalent condition that affects approximately 45% of the adult US population and is the most commonly diagnosed condition at outpatient office visits. Hypertension is a major contributing risk factor for heart failure, myocardia...

Most COVID-19 hospitalizations due to four conditions
https://www.nih.gov/news-events/nih-research-matters/most-covid-19-hospitalizations-due-four-conditions
NIH Research Matters; National Institutes of Health (NIH)

Mar 8th, 2021 - Studies show that certain common medical conditions put people at higher risk for severe illness from COVID-19. These include metabolic disorders like type 2 diabetes and obesity, as well as heart conditions like high blood pressure (hypertension)...

Behavioral Counseling Interventions to Promote a Healthy Diet and Physical Activity for...
https://doi.org/10.1001/jama.2020.21749
JAMA , Krist AH et. al.

Nov 24th, 2020 - Cardiovascular disease (CVD) is a leading cause of death in the US. Known modifiable risk factors for CVD include smoking, overweight and obesity, diabetes, elevated blood pressure or hypertension, dyslipidemia, lack of physical activity, and unhe...

Screening for High Blood Pressure in Children and Adolescents: US Preventive Services T...
https://doi.org/10.1001/jama.2020.20122
JAMA , Krist AH et. al.

Nov 10th, 2020 - Prevalence of hypertension (both primary and secondary) in children and adolescents in the US ranges from 3% to 4%. Primary hypertension in children and adolescents occurs primarily in children older than 13 years and has no known cause but is ass...

see more →

Drugs  9,239 results see all →

Clinicaltrials.gov  169,175 results

ACR Appropriateness Criteria® Radiologic Management of Portal Hypertension.
https://doi.org/10.1016/j.jacr.2021.02.013
Journal of the American College of Radiology : JACR; , Pinchot JW et. al.

May 7th, 2021 - Cirrhosis is a heterogeneous disease that cannot be studied as a single entity and is classified in two main prognostic stages: compensated and decompensated cirrhosis. Portal hypertension, characterized by a pathological increase of the portal pr...

The association between insulin sensitivity indices, ECG findings and mortality: a 40-y...
https://doi.org/10.1186/s12933-021-01284-9
Cardiovascular Diabetology; Moshkovits Y, Rott D et. al.

May 7th, 2021 - Type 2 Diabetes is a major risk factor for cardiovascular (CV) mortality. Insulin resistance can be evaluated non-invasively by insulin sensitivity indices (ISI) such as the Mcauley index (MCAi), which is a function of the fasting insulin and trig...

Clinical impact of blood pressure variability in patients with COVID-19 and hypertension.
https://doi.org/10.1097/MBP.0000000000000544
Blood Pressure Monitoring; Nam JH, Park JI et. al.

May 7th, 2021 - This study aimed to investigate the relationship between blood pressure variability (BPV) and clinical outcomes in patients with coronavirus disease 2019 (COVID-19) and hypertension. A total of 136 patients hospitalized with COVID-19 were enrolled...

Persistent hypertension after preeclampsia in a group of Cameroonians: Result of a cros...
https://doi.org/10.1111/jch.14260
Journal of Clinical Hypertension (Greenwich, Conn.); Nganou-Gnindjio CN, Kenmogne D et. al.

May 7th, 2021 - Preeclampsia/eclampsia significantly increases the risk of future hypertension. Several factors may be involved in this process. The purpose of this study was to identify them in Cameroonians. We conduct a cross-sectional study including women age...

Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the...
https://doi.org/10.1007/s11906-021-01142-9 10.1002/cphy.c120027 10.1016/j.tem.2018.01.002 10.1038/nrgastro.2017.119 10.1371/journal.pone.0096053 10.18632/oncotarget.18528 10.1016/j.jcmgh.2016.03.007 10.1113/jphysiol.2011.219691 10.1038/nrgastro.2017.38 10.1073/pnas.1400062111 10.1016/j.cld.2013.12.001 10.1152/physiolgenomics.00136.2014 10.1161/HYPERTENSIONAHA.120.13896 10.1161/JAHA.119.014373 10.1080/19490976.2018.1441664 10.1016/j.celrep.2018.09.058 10.3748/wjg.v25.i39.5897 10.1155/2014/797898 10.1007/978-3-319-22671-2_11 10.1126/science.1064921 10.1038/nature03120 10.1038/nature03049 10.1101/gad.1953310 10.1038/nrg2290 10.1016/j.trecan.2019.08.003 10.1016/j.trsl.2019.07.007 10.1111/jcmm.12950 10.3748/wjg.v20.i23.7312 10.1038/s41598-018-36297-0 10.3181/0711-RM-321 10.1258/ebm.2011.010349 10.3109/10641963.2015.1116543 10.3390/ijms17040451 10.1038/s41440-019-0248-0 10.1098/rstb.2011.0336 10.33549/physiolres.932364 10.1038/s41440-020-0405-5 10.1186/s12944-019-1028-1 10.1038/s41371-018-0097-3 10.1080/10641963.2016.1226889 10.1038/hr.2016.147 10.1016/j.jash.2015.07.013 10.1016/j.ijcard.2014.09.204 10.1038/jhh.2013.117 10.26355/eurrev_202011_23828 10.1080/10641963.2019.1571597 10.1186/s12967-018-1604-6 10.1016/j.jash.2014.03.324 10.1097/FJC.0b013e318203759b 10.1074/jbc.M109.098004 10.1016/j.devcel.2008.07.008 10.1093/ajh/hpz112 10.1182/blood-2011-08-373886 10.1016/j.phrs.2012.10.007 10.1097/MNH.0000000000000293 10.1186/s40168-016-0222-x 10.1161/HYP.0000000000000065 10.1057/biosoc.2011.1 10.3390/ijerph110403956 10.1016/j.jpeds.2009.01.015 10.1038/ijo.2009.259 10.1152/ajpregu.00680.2007 10.1681/ASN.2009111111 10.1097/HJH.0000000000000551 10.1038/ki.2008.184 10.1016/j.lfs.2006.08.009 10.1152/ajprenal.00063.2004 10.1016/j.jnutbio.2017.02.003 10.1007/s11906-016-0696-8 10.1016/j.envres.2016.01.010 10.3892/etm.2017.5371 10.3389/fphys.2018.01433 10.1097/00004872-200018060-00006 10.3892/etm.2016.3506 10.1016/j.jada.2010.03.018 10.1002/dmrr.488 10.4103/jrms.JRMS_982_17 10.1016/j.molmet.2013.11.006 10.1111/micc.12104 10.1093/jn/130.5.1247 10.1113/JP274623 10.1155/2016/2489479 10.1161/CIRCULATIONAHA.116.023926 10.1161/CIRCRESAHA.113.301824 10.1097/HCO.0000000000000532 10.1152/ajpheart.00389.2018 10.1038/s41420-019-0153-y 10.3389/fmed.2019.00280 10.1152/ajpendo.00348.2014 10.1038/s41598-020-77539-4 10.1161/HYPERTENSIONAHA.110.154187 10.17219/acem/93728 10.1159/000490093 10.1186/s12929-017-0357-5 10.1016/j.jnutbio.2018.03.010 10.1161/01.HYP.0000202568.01167.B6 10.1093/ajh/hpu157 10.1038/jhh.2014.30 10.1161/01.CIR.0000126823.07732.D5 10.1038/sj.ejcn.1602138 10.1111/jch.13075 10.1080/10641963.2016.1226888 10.1016/j.jacc.2005.04.040 10.1038/s41467-017-02401-7 10.1097/00005344-200310000-00001 10.3892/mmr.2015.4558 10.1016/j.bbrc.2019.11.055 10.1038/srep35302 10.1111/1440-1681.12611 10.1161/CIRCULATIONAHA.109.864629 10.1007/s00418-020-01847-z 10.1007/s12013-009-9063-6 10.1079/NRR200116 10.1016/j.jash.2017.04.006 10.1146/annurev-physiol-021317-121134 10.1161/HYPERTENSIONAHA.116.08966 10.1097/MD.0000000000006417 10.1291/hypres.28.819 10.1097/HJH.0000000000001373 10.1111/jcmm.14863 10.1161/HYPERTENSIONAHA.109.144428 10.1161/HYPERTENSIONAHA.111.00892 10.3892/etm.2016.3667 10.1097/01.crd.0000223656.06812.ae 10.1136/bmj.g3961 10.1373/clinchem.2012.195776 10.3389/fendo.2019.00319 10.1210/jc.2015-2357 10.1186/s40608-018-0199-z 10.1016/j.soard.2013.11.010 10.1186/s12920-016-0180-y 10.1152/ajpgi.00048.2011 10.1146/annurev-food-030117-012830 10.1002/mnfr.201900616 10.1161/HYPERTENSIONAHA.118.11695 10.1161/HYPERTENSIONAHA.114.03469 10.1186/s12944-020-01259-x 10.1038/s41598-020-63475-w 10.1161/HYPERTENSIONAHA.118.12588 10.1007/s11906-017-0722-5 10.1016/j.kint.2016.06.033 10.1152/physiolgenomics.00089.2016 10.1073/pnas.1215927110 10.1111/jcmm.14684 10.1016/j.phrs.2018.06.012 10.1016/j.chom.2018.10.001 10.1371/journal.pmed.1003282
Current Hypertension Reports; Golonka RM, Cooper JK et. al.

May 7th, 2021 - To review the current knowledge on interactions between dietary factors and microRNAs (miRNAs) in essential hypertension (EH) pathogenesis. There exists an integration of maintenance signals generated by genetic, epigenetic, immune, and environmen...

see more →

News  10,455 results

Hypertension Worsened by Commonly Used Prescription Meds
https://www.medscape.com/viewarticle/950724

May 6th, 2021 - Nearly one out of five American adults with hypertension is on a prescription drug known to raise blood pressure, based on analysis of more than 27,000 people included in recent reports from the recurring National Health and Nutrition Examination ...

Coffee Intake May Be Driven by Cardiovascular Symptoms
https://www.medscape.com/viewarticle/950416

May 2nd, 2021 - An examination of coffee consumption habits of almost 400,000 people suggests that those habits are largely driven by a person's cardiovascular health. Data from a large population database showed that people with essential hypertension, angina, o...

AHA Issues New Advice on Managing Stage 1 Hypertension
https://www.medscape.com/viewarticle/950205

Apr 28th, 2021 - Clinicians should consider the use of medication for adults with untreated stage 1 hypertension (130–139/80–89 mm Hg) whose 10-year risk for atherosclerotic cardiovascular disease is <10% and who fail to meet the blood pressure goal of <130/80 mm ...

New Study Confirms Kidney Dialysis Worsens Pregnancy Outcomes 
https://www.medscape.com/viewarticle/950184

Apr 28th, 2021 - Women who are pregnant while on dialysis have significantly worse outcomes compared with women who a) have already received a kidney transplant, or b) will eventually start dialysis but had not yet reached that point by the time of their pregnancy...

Preservative-Free Tafluprost/Timolol Fixed Combo Reduces IOP in Open-Angle Glaucoma
https://www.medscape.com/viewarticle/946281

Apr 27th, 2021 - Takeaway Preservative-free tafluprost (0.0015%)/timolol (0.5%) fixed combination (PF-Taf-T-FC) was effective in reducing intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT), inadequately controlled on...

see more →

Patient Education  165 results see all →